Back to the main directory
EarningsReview / Equity
- The weekly navigator by DnB Markets
- Fuelling the future: same, same but different by BNP Paribas Exane
- Epic Pass over macro moguls by BNP Paribas Exane
- CEOs talk ESG by BNP Paribas Exane
- Management Meeting Event Feedback by BNP Paribas Exane
- Writing a new chapter by BNP Paribas Exane
- Day 3 - Tweets and Quotes by BNP Paribas Exane
- Paris postcard: la vie en grey by BNP Paribas Exane
- Macro, Valuation, Exposures, Sensitivities and Performance Sheets by BNP Paribas Exane
- INVEST SECURITIES - MEDESIS : Verdict en défaveur de MEDESIS, 1,4m€ à payer à Bpifrance - NEUTRE, OC 3,3€ (vs 4,1€) by Invest Securities
- Weekly prescription tracker by BNP Paribas Exane
- 视源股份（002841 CH） by HSBC
- Basilea Pharmaceutica - Prompt receipt of milestone payments for Cresemba by Edison Investment Research
- DISH Finally Launches Boost Infinite by BNP Paribas Exane
- Trip.com Group (TCOM US) by HSBC
- Ørsted (Sell, TP: DKK474.00) - Convincing capital discipline by DnB Markets
- Schibsted (Buy, TP: NOK300.00) - Soft Q2e on macro headwinds by DnB Markets
- Few transactions, and SBB Norden further into junk territory by DnB Markets
- Weekly news, topics & discussion by DnB Markets
- Takeaways from Houston by DnB Markets
- It''s bean inflationary by BNP Paribas Exane
- The destock drags on by BNP Paribas Exane
- Passing the low point - raise to Neutral by BNP Paribas Exane
- Going Wal in by BNP Paribas Exane
- Looking for the positives by BNP Paribas Exane